Careers

Description:

About HIV & TB at the Gates Foundation

The strategic vision of the HIV program is to accelerate the reduction in the incidence of HIV infection in high-burden geographies and populations with the goal of achieving sustained epidemic control. We focus our efforts in the poorest hyper-endemic countries of Sub-Saharan Africa, where we believe our resources can have the greatest impact. We work to make lasting reductions in HIV infections by supporting research and development into vaccines, biologics and anti-retroviral drug-based prevention methods.

The strategic vision of the TB program is to accelerate the reduction of Mycobacterium tuberculosis (Mtb) infections in high-burden populations to achieve sustained epidemic TB control. The team aims to address key gaps along the TB care pathway through new approaches to protecting against infection, preventing progression from infection to disease, and improving diagnosis and treatment. Our efforts are diversified based on the understanding that vaccines, diagnostics, drugs, and improved care delivery are all essential to addressing the TB epidemic.

The TB & HIV Director leads the overall strategy for our TB and HIV strategies and coordinates with broader global health efforts within and outside of the foundation to achieve impact.

KEY RELATIONSHIPS

Reports to

President Global Health

Internal Relationships

Gates Medical Research Institute

Discovery & Translational Sciences

Innovative Technology Solutions/HIV Frontiers

Innovation Introduction

Strategic Investment Fund

Vaccine Development & Surveillance

Integrated Development

Africa Country Office

Global Policy, Advocacy & Communications

Global Health Strategy, Planning & Management

External Relationships

NIAID, Division of AIDS (DAIDS), Division of Microbiology and Infectious Diseases (DMID)

NIH Vaccine Research Center

US Military HIV Research Program (MHRP)

Foundation for the NIH (FNIH)

Global multilaterals (e.g. WHO, USAID)

South African partners (e.g. SA-MRC, SA Department of Science & Innovation, Cape Town HIV Immunology Lab (CHIL), University of Cape Town, University of Witwatersrand, Africa Health Research Institute)

International AIDS Vaccine Initiative (IAVI)

Pharma companies (e.g. Merck, J&J/Janssen, GSK, Sanofi, Novartis, Gilead)

Biotech companies (e.g. BioNTech, Moderna, Riethera, Gritstone, JustBio)

Academic partners (e.g. Fred Hutch, Rockefeller U, Duke U, UW, Scripps, Ragon Institute, BIDMC, Mass Gen)

Clinical Trials Networks (HIV Vaccine Trials Network, HIV Prevention Trials Network)

Other global partners (e.g., Global HIV Vaccine Enterprise, European Commission, International AIDS Society)

KEY RESPONSIBILITIES

• Lead the TB & HIV programs, including strategy development, execution, staffing, management and guidance of the team, synthesis and sharing of learning, and assessment of impact;
• Build and nurture a high-performing team, including development of others by identifying and mentoring high performers and building a culture of inclusion and collaboration; delegate responsibility and empower others;
• Cultivate critical collaborative relationships with peers and internal stakeholders;
• Conceptualize and articulate strategies contributing to the reduction of TB & HIV incidence and global burden of disease. Areas of focus include:
  • Understand the TB and HIV epidemics and disease burden trends and continue to evolve research and development strategies that will address this burden
  • Prioritize innovative discovery and delivery implementation approaches, as well as more advanced product development efforts
  • Support and continue to evolve the foundation’s collaborative network models for TB & HIV vaccine, drug and diagnostic discovery and development
• Actively pursue synergies across foundation program, affiliates, functions, country teams, and external partner efforts that contribute to TB & HIV goals;
• Oversee the TB and HIV portfolios and enforce robust team practices that ensure quality technical execution of programs, quality grantee interactions, balance in the portfolio and effective annual planning;
• Provide rigorous reviews of our work that incorporate internal and external stakeholders, consider the global TB & HIV prevention landscapes, and steer mid-course corrections where needed;
• Maintain and establish strong, collaborative relationships with key global partners and stakeholders, including both public and private entities, grantee organizations, governments, multilaterals, other funders, universities, and other valued partners;
• Publicly represent the foundation TB & HIV programs on the global stage.

DESIRED OUTCOMES

• Priorities and progress across the TB & HIV portfolio are rigorously tracked through milestones based, timeline-driven program management
• Existing advanced vaccine and drug clinical development programs efficiently advance to licensure and ultimate product launch in the populations that would most benefit from their use
• Promising novel vaccines, biologics, long-acting drugs and multipurpose prevention technologies are identified and advanced to proof-of-concept
• TB and HIV prevention interventions with defined characteristics are effectively and prospectively linked to implementation research efforts in an effort to maximize probability of delivery success and overall impact

CANDIDATE PROFILE

The ideal candidate will have a MD in Infectious Diseases and be a global thought leader in research and development of TB and HIV prevention interventions. With proven scientific, strategic planning and managerial skills, s/he will have a strong analytical, evidence-based approach to TB and HIV discovery and product development and be credible across the nexus of research, development, policy, advocacy, programmatic delivery, and the monitoring and evaluation of results.

IDEAL EXPERIENCE

Managerial acumen

A track record of leading teams of high-performing professionals with deep technical backgrounds; experience creating and leading large, complex collaborative networks of leading scientists and researchers; experience creating and leading innovative programs and initiatives.

Technical expertise

Deep technical knowledge of the research and development of TB and HIV tools. MD in Infectious Diseases.

Grant management and portfolio experience

Familiarity with the design and rigorous management of complex grants and programs in partnership with industry and/or academia aimed at the discovery and development of TB and HIV tools.

Global Leader & networks

A thought leader in the global arena who can connect with the pharma and biotech sectors, academic institutions, multilaterals, NGOs, and governments.

CRITICAL LEADERSHIP CAPABILITIES

Strategic Thinking

• Defines the evolving goals of the TB & HIV strategy within the foundation with an intellectual agility that incorporates others’ views and new information.
• Leads a TB & HIV strategy and vision that:
  • Moves between the conceptual and the applied, integrating and constructively challenging current issues and initiatives, core values, and future needs in a clear and coherent way.
  • Provides a clear strategic direction for the TB & HIV team – and the foundation – that is based on analytical rigor in goal-setting, large scale project management, and impact measurement.
• Thinks at least five years ahead to anticipate needed shifts in strategy in response to scientific and other learnings.

Collaborating and Influencing

• Systematically builds support at multiple levels and across groups using complex, coordinated influence management skills that are adapted to people, organizations and networks.
• Engages global leaders from the private and public sectors, building support at the highest levels
• Builds partnerships based on a common agreement that acknowledges individual differences but creates a new commonality beyond root beliefs or culture.
• Inspires key stakeholders to create opportunities and participate in driving meaningful change using well-honed verbal and written communication and presentation skills.

Leading People

• Brings together team members with diverse backgrounds, approaches, and beliefs to pursue a coherent long-term direction, and collaborates with the team on how to achieve it.
• Actively contributes, and leads by example, to our ‘Culture for Impact’.
• Delegates objectives with clear and explicit intent to a team with high technical acumen, allowing the freedom to be creative in devising strategies.
• Sets up practices to reinforce independent and open communication among team members and other groups within the foundation that contribute to the work of the TB & HIV program.
• Holds people accountable for their commitments, providing clarity and assisting when barriers arise; maintains the team’s focus on results, int